TY - JOUR T1 - Chemotherapy for metastatic colorectal cancer JF - Drug and Therapeutics Bulletin JO - Drug Ther Bull SP - 49 LP - 52 DO - 10.1136/dtb.2002.40749 VL - 40 IS - 7 A2 - , Y1 - 2002/07/01 UR - http://dtb.bmj.com/content/40/7/49.abstract N2 - Relevant BNF section: 8.1Of the 30,000 people in the UK who develop colorectal cancer each year, around 70-80% undergo potentially curative surgery. Even so, around a half of all patients eventually die from metastatic disease,1 typically within 5 years of diagnosis. Many patients who develop metastases are offered systemic chemotherapy to try to extend survival and maintain or improve quality of life. How effective is such intervention? ER -